Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Marc Ziegler »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Marc Vérin < Marc Ziegler < Marcel Goldberg  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000455 (2003) Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study
000552 (1999) Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France]A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
000572 (1998) Potagas [France] ; George Dellatolas [France] ; Marc Ziegler [France] ; Jean Leveteau [France] ; Nguyen Bathien [France] ; Patrick Mac Leod [France] ; Pierre Rondot [France]Clinical assessment of olfactory dysfunction in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Adult
3Aged
3Female
3Humans
3Male
3Middle Aged
3Parkinson's disease
2Aged, 80 and over
2Agonist
2Antiparkinson Agents (administration & dosage)
2Antiparkinson agent
2Chemotherapy
2Dopamine receptor
2Double-Blind Method
2Follow-Up Studies
2Human
2Parkinson Disease (diagnosis)
2Parkinson Disease (drug therapy)
2Parkinson disease
2Piribedil
2Piribedil (administration & dosage)
2Treatment
2Treatment Outcome
1Administration, Cutaneous
1Analysis of Variance
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (pharmacology)
1Attention (physiology)
1Discrimination (Psychology) (physiology)
1Discrimination Learning (physiology)
1Dopamine Agonists (administration & dosage)
1Dopamine Agonists (pharmacology)
1Dose-Response Relationship, Drug
1Double blind study
1Drug Administration Schedule
1Drug Therapy, Combination
1Drug combination
1Levodopa
1Levodopa (administration & dosage)
1Levodopa (adverse effects)
1L‐dopa
1Mental Recall (physiology)
1Odor discrimination
1Odor identification
1Olfaction
1Olfaction Disorders (diagnosis)
1Olfaction Disorders (physiopathology)
1Olfactory testing
1Parkinson Disease (physiopathology)
1Patch
1Pattern Recognition, Visual (physiology)
1Phase II trial
1Piribedil (adverse effects)
1Piribedil (pharmacology)
1Sensory Thresholds (physiology)
1Transdermal patch
1Transdermal system
1Treatment efficiency
1nonfluctuating patients
1piribedil

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Marc Ziegler" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Marc Ziegler" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Marc Ziegler
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024